Memphasys LtdASX: MEM

Memphasys Investor Webinar Presentation - September 2026

Sep 7, 2026 at 7:01 PM EDT · Issued by Memphasys Ltd via ASX

Filed with ASX · Sep 7, 2026 at 7:01 PM EDT

On 6ix: 6ix.com/news/memphasys-investor-webinar-presentation-september-2026

MEMPHASYS · ASX: MEMASX: MEM | INVESTOR PRESENTATION · SEPTEMBER 2026Felix: From Clinical Validationto Global Commercial ScaleRegulatory approvals secured.Major commercial partners activated.Recurring cartridge revenue beginning to scale.MEMPHASYS · ASX: MEM1COMMERCIAL INFLECTION...

View Attachment

6ix hasn’t read this filing yet.

Memphasys Ltd on 6ix

In the deck

Memphasys — Investor Presentation (September 2026)16 slidesSep 8, 2026

Earlier from Memphasys

Investor Webinar InviteSep 3
Felix Registration Achieved in Turkey, Sales CommenceSep 2
Notification of cessation of securities - MEMSep 1
EUR526,500 Nordic Agreement Expands Felix European FootprintAug 31
Appendix 4G and Corporate Governance StatementAug 31

Later from Memphasys

Memphasys Secures European Felix AgreementSep 17
Application for quotation of securities - MEMSep 18
Notification regarding unquoted securities - MEMSep 18
Change of Director's Interest NoticeSep 20
Potential Expedited FDA Pathway to US IVF MarketSep 24

All Memphasys news releases

Follow Memphasys into a list and get an email when it puts out news.

Follow Memphasys